<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                                       Cell Death Differentiation (2011) 18, 1757&#226;&#8364;&#8220;1770 <br />                                                                                        &amp; 2011 Macmillan Publishers Limited All rights reserved 1350-9047/11 <br />                                                                                        www.nature.com/cdd <br />  <br />  <br /> Integration CNS <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span>survival</span> differentiation HIF2a <br /> C-Y Ko1, M-Y Tsai2,3, W-F Tseng4, C-H Cheng5, C-R Huang1,9, J-S Wu1, H-Y Chung1, C-S Hsieh6, C-K Sun6, S-PL Hwang3, C-H Yuh4, <br /> C-J Huang5, T-W Pai7,8, W-S Tzou1,8 C-H Hu*,1,8 <br />  <br />  <br /> Hypoxia-inducible factor (HIF) 1a HIF2a inhibitor apoptosis survivin represent prominent markers human <br /> cancers. They widely expressed various embryonic tissues, including central nervous system; however, little is <br /> known functions embryos. Here, zebrafish HIF2a protects neural progenitor cells neural <br /> differentiation processes upregulating survivin orthologues birc5a birc5b embryogenesis. Morpholino- <br /> mediated knockdown hif2a reduced transcription birc5a birc5b, induced p53-independent apoptosis abrogated <br /> neural cell differentiation. Depletion birc5a birc5b recaptured neural development defects observed the <br /> hif2a morphants. The phenotypes induced HIF2a depletion largely rescued ectopic birc5a birc5b mRNAs, <br /> indicating Birc5a Birc5b act downstream HIF2a. Chromatin immunoprecipitation assay revealed HIF2a binds <span id='am-3' about='protege:TO' typeof='owl:Thing'>to</span> <br /> birc5a birc5b promoters directly modulate transcriptions. Knockdown hif2a, birc5a birc5b reduced the <br /> expression cdk inhibitors p27/cdkn1b p57/cdkn1c increased ccnd1/cyclin D1 transcription surviving neural <br /> progenitor cells. The reduction elavl3/HuC expression enhanced pcna, nestin, ascl1b sox3 expression indicate that <br /> the surviving neural progenitor cells hif2a morphants maintain high proliferation rate terminally differentiating. <br /> We propose subset developmental defects attributed HIF2a depletion loss survivin activity. <br /> Cell Death Differentiation (2011) 18, 1757&#226;&#8364;&#8220;1770; doi:10.1038/cdd.2011.44; published online 6 May 2011 <br />  <br />  <br /> Hypoxia-inducible factors (HIFs), including HIF1, HIF2                             malformations, dysregulated erythropoiesis signaling, and <br /> HIF3, known function oxygen homeostasis                                   marked cell death cephalic mesenchyme.4&#226;&#8364;&#8220;6 HIF2a <br /> regulating genes responsible glucose uptake                                null (HIF2a / ) embryos died result inadequate blood <br /> metabolism, erythropoiesis, angiogenesis, apoptosis cell                           vessel fusion, remodeling impaired fetal lung matura- <br /> proliferation.1 The HIFs heterodimeric basic-helix-loop-                           tion.7,8 Inhibition HIF2a expression enhanced the <br /> helix-PAS transcription factors consist oxygen-                             generation reactive oxygen species (ROS) reduced <br /> regulated subunit constitutively expressed b subunit,                          transcription primary anti-oxidant enzymes (AOEs), which <br /> which known ARNT.1 In normoxic conditions,                             turn caused syndrome multiple-organ pathology.9 <br /> HIF1a HIF2a targeted proteosomal degradation                            Neural cell-specific depletion HIF1a resulted hydro- <br /> prolyl hydroxylase von Hippel&#226;&#8364;&#8220;Lindau (VHL) E3 ligase                           cephalus accompanied increase neuron cell <br /> complex.2 When cells subjected hypoxia, HIF-a                               apoptosis vascular regression telencephalon of <br /> factors stabilized turn associate ARNT                             mutant mouse embryos.10 <br /> activate target genes.2 HIF3a lacks conventional C-terminal                             Depending severity hypoxia, hypoxic signals may <br /> transactivation domain postulated act negative                       induce different responses cell death. For pro- <br /> regulator hypoxia-inducible gene expression.3                                       apoptotic pathway, HIF1a conspires p53 and/or BNIP3 to <br />    Despite oxygen homeostatic functions adult tissues,                        promote apoptosis.11,12 However, hypoxia induce an <br /> HIF-related pathways critical functions embryos.                          anti-apoptotic response increasing expression the <br /> Constitutive depletion mouse HIF1a gene (HIF1a / )                              anti-apoptotic protein IAP2 suppressing expression of <br /> results developmental arrest embryonic lethality,                         pro-apoptotic protein Bax HIF1a-independent <br /> is characterized neural tube defects, cardiovascular                                mechanism.13 A recent study shown HIF2a be <br />  <br /> 1 <br />  Institute Bioscience Biotechnology, National Taiwan Ocean University, Keelung, Taiwan, ROC; 2Graduate Institute Life Sciences, National Defense Medical <br /> Center, National Defense University, Neihu, Taipei, Taiwan, ROC; 3Institute Cellular Organismic Biology, Academia Sinica, Taipei, Taiwan, ROC; 4Division <br /> of Molecular Genomic Medicine, National Health Research Institutes, Zhunan, Taiwan, ROC; 5Institute Biological Chemistry, Academia Sinica, Taipei, Taiwan, ROC; <br /> 6 <br />  Department Electrical Engineering, National Taiwan University, Taipei, Taiwan, ROC; 7Department Computer Science Engineering, National Taiwan Ocean <br /> University, Keelung, Taiwan, ROC 8Center Excellence Marine Bioenvironment Biotechnology, National Taiwan Ocean University, Keelung, Taiwan, ROC <br /> *Corresponding author: C-H Hu, Institute Bioscience Biotechnology, National Taiwan Ocean University, 2 Pei-Ning Road, Keelung 20224, Taiwan, ROC. <br /> Tel: &#195;&#190; 886 22 462 2192, ext: 5506; Fax: &#195;&#190; 886 22 462 2320; E-mail: chhu@mail.ntou.edu.tw <br /> 9 <br />  Current address: Institute Bioinformatics Biosignal Transduction, National Cheng Kung University, Tainan, Taiwan, ROC. <br /> Keywords: HIF2a; surviving; neural progenitor cells; apoptosis <br /> Abbreviations: AO stain, acridine orange stain; AOE, anti-oxidant enzyme; ascl1b, achaete-scute complex-like 1b; BIR domain, baculovirus IAP repeat domain; <br /> ccnd1, cyclin D1; ccRCC, clear cell renal cell carcinoma; cdkn1b/1c, cyclin-dependent kinase inhibitor 1b (p27/kip1)/1c (p57/kip2); ChIP, chromatin immunoprecipitation; <br /> CNS, central nervous system; DAPI, 40 ,6-diamidino-2-phenylindole; Dpp, decapentaplegic; elavl3, ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu <br /> antigen C); EMSA, electrophoretic mobility shift assay; HIF, hypoxia-inducible factor; HuC/D, Hu antigen C/D; IAP, inhibitor apoptosis protein; MO, morpholino <br /> oligonucleotide; NPCs, neuronal progenitor cells; PCNA, proliferation cell nuclear antigen; ROS, reactive oxygen species; VHL, von Hippel&#226;&#8364;&#8220;Lindau protein; TUNEL, <br /> terminal transferase dUTP Nick End Labeling; Wg, wingless <br /> Received 17.9.10; revised 28.2.11; accepted 23.3.11; Edited N Chandel; published online 06.5.11 <br />                                   Integration CNS survival differentiation HIF2a <br />                                                                                C-Y Ko et al <br /> 1758 <br />  <br />           involved anti-apoptotic properties tumor cells.                              In addition massive apoptosis, morphological <br />           Inhibition HIF2a promoted p53 activity induced tumor                         abnormality small acellular head observed in <br />           cell death disturbing cellular redox homeostasis                             hif2a morphants 48-h.p.f. stage (Figure 1h). During <br />           promoting accumulation ROS.14                                                early stage development, massive apoptosis elicited <br />             Survivin (Birc5) smallest member inhibitor                       hif2a morpholino 12-h.p.f. stage any <br />           apoptosis proteins (IAPs) contains single baculovirus                         morphological defect observed (Figures 1j k). Moreover, <br />           IAP repeat (BIR) domain extended C-terminal a-helical                        pcna expression anterior proliferative region was <br />           coiled-coil domain.15 In addition inhibiting apoptosis,                          diminished 12-h.p.f. stage, possibly the <br />           survivin important functions cell mitosis cell-                     considerable cell death (Figures 1l m). It suggests that <br />           cycle progression.16 The mammalian survivin protein widely                       gross developmental abnormalities observed hif2a <br />           expressed embryonic cells, especially neural progenitor                       morphants possibly caused extensive cell death <br />           cells, barely detectable quiescent adult cells.17                      occurred early stage development. <br />           During brain development, survivin highly expressed                              A similar anti-apoptotic function observed the <br />           neural progenitor cells. Targeted deletion survivin neural                    human HIF2a protein. siRNA-mediated knockdown HIF2a <br />           precursor cells leads massive apoptosis central                           promoted p53 activity human tumor cells induced cell <br />           nervous (CNS) elevated caspase-3                                  death disturbing cellular redox homeostasis and <br />           caspase-9 activities.18 Interestingly, survivin widely                           prompting accumulation ROS.14 To examine whether <br />           expressed kinds malignant tumors, making potent                      hif2a morpholino-induced apoptosis zebrafish embryos <br />           target cancer therapy.15,19                                                     mediated p53 activity, concurrently knocked down <br />             There multiple HIFa factors, including HIF1a, HIF2a                       p53 hif2a using translational morpholinos. Our results <br />           HIF3a, zebrafish widely expressed devel-                         depletion p53 expression did block the <br />           opment.20,21 Concurrent knockdown factors                            massive apoptosis induced treatment hif2a morpho- <br />           leads neural cell death abrogates neuronal develop-                          linos (Figures 1n o). Similarly, severe apoptosis was <br />           ment, indicating HIF-a factors critical roles                    observed p53M214K mutant embryos injection a <br />           neural <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span>cell survival</span> differentiation.20 Nevertheless,                       hif2a translation-blocking MO (Figures 1p q), indicating <br />           authentic HIF-a factor responsible fates CNS                             HIF2a depletion-induced apoptosis off-target <br />           neuronal progenitor cells (NPCs) remains elucidated.                          effect morpholino mediated a <br />           Here, demonstrate HIF-a factors, HIF2a                         p53-independent pathway. <br />           major role maintaining cell survival promotes                             To verify apoptotic cells observed hif2a <br />           neural progenitor cell differentiation. HIF2a depletion caused                      morphants undifferentiated NPCs, embryos first <br />           massive cell death abrogated neural cell differentiation                        situ hybridized fluorescence nestin (nes) RNA probe <br />           aberrant expression survivin homologs (birc5a                         followed TUNEL assay. We apoptotic <br />           birc5b). The surviving NPCs remained cell cycle.                         cells colocalized nes-positive cells (as labeled <br />           The defects appeared hif2a morphant embryos                            yellow Figures 1r s), indicating apoptotic cells in <br />           rescued ectopic injection birc5a birc5b mRNA,                          hif2a morphants NPCs. <br />           suggesting survivins act downstream HIF2a protect <br />           neural progenitor cells promote neural differentiation.                         Knockdown hif2a abrogates CNS differentiation. We <br />           Chromatin immunoprecipitation assay revealed HIF2a                             examined fate surviving NPCs hifa <br />           binds birc5a birc5b promoters directly modulate                      morphant embryos using terminal differentiation marker <br />           transcriptions.                                                               elavl3. Knockdown hif2a caused dramatic reduction in <br />                                                                                               elavl3 transcription (Figures 2b, c m) compared with <br />                                                                                               wild-type embryos (Figure 2a) types hifa <br />           Results                                                                             morphants (Figures 2d&#226;&#8364;&#8220;f m), indicating loss hif2a <br />                                                                                               expression stimulated NPC apoptosis also <br />           HIF2a knockdown induces p53-independent apoptosis.                                  abrogated differentiation cells. The loss neural <br />           There multiple HIF-a factors, including HIF1a, HIF2a                        differentiation hif2a morphants confirmed lack <br />           HIF3a, zebrafish widely expressed                                HuC/D expression (Figure 2h) acetylated a-tubulin <br />           development.20,21 Concurrent knockdown                               (Figure 2k). Consistent observation, hif2a <br />           factors leads neural cell death abrogates neuronal                           morphants higher transcript levels neural <br />           development.20 To clarify particular HIF factor                          progenitor markers, nes, sox3 achaete-scute <br />           determines fates zebrafish CNS NPCs, analyzed                             complex-like 1b (ascl1b), compared control embryos in <br />           apoptotic events individual hifa morphant embryos. We                            late stages development (Figures 3a&#226;&#8364;&#8220;f), suggesting <br />           knockdown hif2a distinct anti-                       NPCs retained undifferentiation stage. The <br />           sense morpholinos resulted massive apoptosis                              high level PCNA expression CNS suggests the <br />           24- 48-h post-fertilization (h.p.f.) stage (Figures 1a&#226;&#8364;&#8220;c, g&#226;&#8364;&#8220;                    undifferentiated NPCs hif2a morphants maintain high <br />           h t). Conversely, knockdown hif1a hif3a                           level proliferation (Figures 3h j). Moreover, the <br />           individually concurrently did increase number                         reduction expression cdk inhibitors cdkn1b <br />           apoptotic cells (Figures 1d&#226;&#8364;&#8220;f, t), indicating HIF2a                      (Figures 4a, b g) cdkn1c CNS region (Figures <br />           unique function protecting embryonic cells                         4c, d h) accompanied increase ccnd1 <br />           apoptosis.                                                                          transcription (Figures 4e, f i), indicating NPCs the <br />  <br /> Cell Death Differentiation <br />                                                                                           Integration CNS survival differentiation HIF2a <br />                                                                                          C-Y Ko et al <br />                                                                                                                                                                                   1759 <br />  <br />  <br />  <br />  <br /> Figure 1 HIF2a protects CNS neural progenitors cell death. (a&#226;&#8364;&#8220;f) Lateral views acridine orange (AO) staining wild-type (WT; a), hif2a translation-blocking MO <br /> (hif2a ATG-MO; b), hif2a SPL-MO (c), hif1a ATG-MO (d), hif3a ATG-MO (e) hif1a, hif3a dual ATG-MO (f) 24 h.p.f. embryos. The apoptotic cells labeled white <br /> spots. (g&#226;&#8364;&#8220;i) Transverse brain sections TUNEL (bright green) DAPI (blue) staining WT (g), hif2a ATG-MO (h) hif1a, hif3a dual ATG-MO (i) 48 h.p.f. embryos. <br /> (j k) Lateral views acridine orange (AO) staining WT (j), hif2a ATG-MO (k) 12 h.p.f. embryos. (l m) Lateral views pcna expression WT (l) hif2a ATG-MO <br /> (m) 12 h.p.f. embryos. (n o) Apoptosis analysis p53 ATG-MO (n) p53, hif2a dual ATG-MO (o) 24 h.p.f. embryos AO staining. (p q) Apoptosis analyses of <br /> control (p) hif2a ATG-MO (q) 42 h.p.f. p53M214K mutant embryos AO staining. (r s) Colocalization TUNEL signaling (in green) nes expression (in red) WT <br /> (r) hif2a ATG-MO (s) 56 h.p.f. embryos. nes stained fluorescence situ hybridization. The TUNEL-positive, nes-positive cells (in yellow) represent apoptotic <br /> NPCs. (t) Percentages normal, moderate severe apoptosis WT control (n &#194;&#188; 112), hif1a ATG-MO (n &#194;&#188; 72), hif2a ATG-MO (n &#194;&#188; 114), hif2a SPL-MO (n &#194;&#188; 66), <br /> hif3a ATG-MO (n &#194;&#188; 50) hif1a, hif3a dual ATG-MO (n &#194;&#188; 137) embryos <br />  <br />  <br /> hif2a morphants did exit normally cell cycle. It                        gene expression CNS hif2a morphants <br /> further supported double fluorescent situ hybridization                         (yellow Figure 4o) suggesting NPCs these <br /> nes ccnd1 expression (Figures 4j&#226;&#8364;&#8220;o). The colocalization                           hif2a morphants hyperproliferating cells. <br />  <br />                                                                                                                                                           Cell Death Differentiation <br />                                    Integration CNS survival differentiation HIF2a <br />                                                                                 C-Y Ko et al <br /> 1760 <br />  <br />  <br />  <br />  <br />           Figure 2 Knockdown hif2a impairs CNS development. (a&#226;&#8364;&#8220;f) Lateral views elavl3 expression WT (a), hif2a ATG-MO (b), hif2a SPL-MO (c), hif1a ATG-MO (d), hif3a <br />           ATG-MO (e) hif1a, hif3a dual ATG-MO (f) 24 h.p.f. embryos. elavl3 expression CNS decreased greatly hif2a ATG-MO hif2a SPL-MO treatments, <br />           indicating NPCs terminally differentiated. (g&#226;&#8364;&#8220;i) Immunofluorescent staining HuC/HuD (in red) transverse brain sections WT (g), hif2a ATG-MO (h) <br />           hif1a, hif3a dual ATG-MO (i) 48 h.p.f. embryos. Nuclei labeled DAPI staining (in blue). Consistent mRNA transcriptional activity, knockdown hif2a <br />           eliminated HuC expression, indicating defect neural differentiation. Knockdown hif2a caused morphological abnormality small head. (j&#226;&#8364;&#8220;l) Dorsal views of <br />           whole-mount immunostained images acetylated a-tubulin WT (j), hif2a ATG-MO (k) hif1a/hif3a ATG-MO (l) 24 h.p.f. embryos. Axons visualized antibody <br />           staining acetylated a-tubulin. The neural development defect following hif2a MO treatment reflected loss axon growth. (m) Percentages normal, moderate <br />           severe loss elavl3 expression WT control (n &#194;&#188; 50), hif1a ATG-MO (n &#194;&#188; 54), hif2a ATG-MO (n &#194;&#188; 69), hif2a SPL-MO (n &#194;&#188; 23), hif3a ATG-MO (n &#194;&#188; 25) and <br />           (n &#194;&#188; 64) embryos. Knockdown hif2a translation-blocking splicing-blocking MOs led severe loss elavl3 transcription, indicating impairment neural <br />           differentiation <br />  <br />  <br />  <br />  <br /> Cell Death Differentiation <br />                                                                                                Integration CNS survival differentiation HIF2a <br />                                                                                               C-Y Ko et al <br />                                                                                                                                                                                           1761 <br />  <br />  <br />  <br />  <br /> Figure 3 The surviving neural progenitor cells hif2a morphants continue proliferate terminally differentiating. (a&#226;&#8364;&#8220;f) Lateral views nes (a b), sox3 (c d) and <br /> ascl1b (e f) expression WT (a, c e) hif2a ATG-MO (b, d f) 48 h.p.f. embryos. nes, sox3 ascl1b highly expressed NPCs mature <br /> neural cells. The high level nes, sox3 ascl1b transcriptions hif2a morphants suggests NPCs did differentiate mature neural cells. (g h) Lateral <br /> views pcna transcription WT (g) hif2a ATG-MO (h) 48 h.p.f. embryos. (i j) Immunofluorescent staining PCNA (in red) transverse brain sections WT (i) and <br /> hif2a ATG-MO (j) 48 h.p.f. embryos. Nuclei labeled DAPI staining (in blue). The increased pcna expression CNS hif2a MO embryos indicates NPCs <br /> were proliferating <br />  <br />  <br /> Survivins function downstream HIF2a protect                                             i), indicating hif2a correlates survivin <br /> neural      progenitor      cells       promote     neural                                expression. Conversely, concurrent depletion hif1a and <br /> differentiation. Survivin smallest member IAP                                   hif3a did affect transcription birc5a birc5b <br /> family multiple functions cell survival, mitosis                                   (Figures 5f&#226;&#8364;&#8220;i). This suggests zebrafish survivin <br /> and proliferation. Knockdown zebrafish survivin                                        orthologues affected specifically HIF2a by <br /> orthologues birc5a birc5b causes profound neuro-                                          HIF-a factors. To determine survivin <br /> developmental, hematopoietic, cardiogenic, vasculogenic                                       deficiency accounts HIF2a depletion-induced NPC <br /> and angiogenic defects.22 Together, results suggest                                     apoptosis aberrant neural differentiation, examined <br /> that survivin functions embryonic development. In various                                  NPC apoptosis neural differentiation birc5a and <br /> human cancer cells, survivin/BIRC5 transcription upregu-                                   birc5b morphant embryos. Knockdown birc5a or <br /> lated result increases HIF1a.23 This raises                                    birc5b caused considerable increases apoptosis and <br /> possibility survivin orthologues zebrafish                               morphological abnormality, similar that <br /> affected HIF factors. Here, analyzed                                     observed hif2a morphant embryos (Figures 6a, b, g, h, <br /> transcriptional activities survivin orthologues birc5a                                 7a&#226;&#8364;&#8220;c 8). Additionally, birc5a birc5b morphants <br /> and birc5b various hifa morphant embryos. In wild-type                                     exhibited lower levels elavl3 transcription compared <br /> embryos, survivin orthologues birc5a birc5b                                       WT controls (Figures 6c, e i&#226;&#8364;&#8220;l). Likewise, birc5a <br /> hif2a transcribed intensively CNS region                                      birc5b morphants exhibited higher levels nes and <br /> (Figures 5a&#226;&#8364;&#8220;c). Depletion HIF2a resulted reduction                                 pcna transcription compared controls (Figures 9a&#226;&#8364;&#8220;i). <br /> the transcription birc5a birc5b (Figures 5d, e, h                                 Moreover, birc5a birc5b morphant embryos had <br />  <br />                                                                                                                                                                   Cell Death Differentiation <br />                                      Integration CNS survival differentiation HIF2a <br />                                                                                   C-Y Ko et al <br /> 1762 <br />  <br />  <br />  <br />  <br />           Figure 4 The surviving neural progenitor cells hif2a morphants exit normally cell cycle. (a&#226;&#8364;&#8220;f) Lateral views cdkn1b (a b), cdkn1c (c d) and <br />           ccnd1c (e f) expression WT (a, c e) hif2a ATG-MO (b, d f) 48 h.p.f. embryos. (g&#226;&#8364;&#8220;i) Quantitative RT-PCR cdkn1b (g), cdkn1c (h) ccnd1 (i) genes <br />           WT, hif2a ATG-MO hif1a, hif3a dual ATG-MO 24 h.p.f. embryos. Decreased cdkn1b cdkn1c expression increased ccnd1 expression CNS hif2a <br />           morphants suggest NPCs failed exit cell cycle. (j&#226;&#8364;&#8220;o) Double fluorescent situ hybridizations nes (red; j k) ccnd1 (green; l m) WT (j, l n) and <br />           hif2a ATG-MO (k, m o) 48 h.p.f. embryos. Merged images (n o) shown. The colocalization nes ccnd1 (in yellow) expressions hif2a morphants indicates <br />           surviving NPCs hyperproliferating cells <br />  <br />  <br />           lower levels cdkn1b cdkn1c transcription higher                                      HIF2a binds birc5a birc5b promoters. Since <br />           levels ccnd1 transcription control embryos (Figures                                     depletion HIF2a resulted reduction the <br />           9j&#226;&#8364;&#8220;r). Together, observations indicate knockdown                                     transcription birc5a birc5b, raises possibility <br />           birc5a birc5b results induction NPC                                      HIF2a controls survivin orthologues through <br />           apoptosis inhibition cell-cycle exit NPCs,                                    direct interactions promoters. We retrieved the <br />           similar <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span>phenotype</span> observed hif2a                                         upstream sequence bric5a birc5b genes <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br />           morphant embryos. Moreover, ectopic treatment                                          UCSC genome website (http://genome.ucsc.edu/) and <br />           birc5a birc5b mRNA successfully prevented hif2a                                     identified multiple hypoxia-response element (HRE) core <br />           MO-induced apoptosis morphological abnormality                                              sequences (A/GCGTG) promoter regions (Figure 10c). <br />           (Figures 6m, n, 7d 8), restored elavl3 expression                                  Similar multiple HRE core sequences identified in <br />           nearly normal level (Figures 6o&#226;&#8364;&#8220;r), indicating                                    human mouse BIRC5 promoters (Figure 10c). To <br />           survivin orthologues rescue impairment NPC                                        determine zebrafish HIF2a binds HRE specifically, <br />           development caused HIF2a deficiency.                                                 oligonucleotides containing HRE core sequence ACGTG <br />  <br /> Cell Death Differentiation <br />                                                                                           Integration CNS survival differentiation HIF2a <br />                                                                                          C-Y Ko et al <br />                                                                                                                                                                                  1763 <br />  <br />  <br />  <br />  <br /> Figure 5 Knockdown hif2a reduces expression survivin orthologues. (a&#226;&#8364;&#8220;c) Lateral views hif2a (a), birc5a (b) birc5b (c) transcription 24 h.p.f. WT <br /> embryos. Expression transcripts overlapped CNS region. (d&#226;&#8364;&#8220;g) Lateral views birc5a (d f) birc5b (e g) expression hif2a ATG-MO (d e) <br /> and hif1a, hif3a dual ATG-MO (f g) 24 h.p.f. embryos. The expression levels birc5a birc5b reduced hif2a morphants. (h i) Quantitative RT-PCR of <br /> the birc5a (h) birc5b (i) genes WT, hif2a ATG-MO hif1a, hif3a dual ATG-MO 24-h.p.f. stage embryos. Expression normalized b-actin. Knockdown hif2a <br /> caused reduction transcription birc5a birc5b <br />  <br />  <br />  <br /> were synthesized, biotin labeled electrophoretic mobility                            significantly enriched HIF2a antibody (Figures 10b <br /> shift assay (EMSA) carried (Figure 10a). When                                    c), suggesting HIF2a binds directly birc5a and <br /> HIF2a expressed coexpressed                                     bric5b promoters modulate expressions. <br /> ARNT1a COS-1 cells, mobility complex formed with <br /> wild-type HRE probe (lanes 3 4). This mobility complex <br />                                                                                          Discussion <br /> was effectively competed 200-fold molar excess the <br /> unlabeled HRE (lane 5). Conversely, mobility complex                                 HIFa survivin prominent markers human <br /> was, however, unaffected 200-fold molar excess                               cancers critical roles cell apoptosis and <br /> unlabeled mutated HRE (lane 6). These observations                                       proliferation. Previously, depletion of the <br /> demonstrated transfected HIF2a binds HRE                                   HIF factors caused massive apoptosis brains of <br /> sequence specificity.                                                                    zebrafish embryos.20 Here, showed HIF-a <br />    To examine HIF2a binds directly birc5a                                 factors, HIF2a factor modulates neural progenitor <br /> bric5b promoter vivo, immunoprecipitated crosslinked                               cell growth differentiation downstream <br /> chromatin adult brain tissue HIF2a-specific                                  effects survivin orthologues, Birc5a Birc5b. <br /> antibody. The precipitated chromatin analyzed                                Depletion HIF2a expression caused reductions of <br /> PCR using primer pairs amplified modules spanning                               birc5a birc5b transcripts, turn elicited <br /> birc5a bric5b loci. The ChIP assay demonstrated                             massive apoptosis abrogated neural progenitor <br /> module 5 birc5a modules 2 6 birc5b                                    cell differentiation. Although human survivin (BIRC5) and <br />  <br />                                                                                                                                                          Cell Death Differentiation <br />                                    Integration CNS survival differentiation HIF2a <br />                                                                                 C-Y Ko et al <br /> 1764 <br />  <br />  <br />  <br />  <br />           Figure 6 Survivin orthologues function downstream HIF2a control CNS development. (a b) Transverse brain sections TUNEL staining 48 h.p.f. wild-type <br />           (WT; a) hif2a ATG-MO (b) embryos. (c d) Lateral views elavl3 expression WT (c) hif2a ATG-MO (d) 24 h.p.f. embryos. (e f) Immunofluorescent staining <br />           HuC/HuD (in red) transverse brain sections WT (e) hif2a ATG-MO (f) 48 h.p.f. embryos. Nuclei labeled DAPI staining (in blue). (g h) Transverse brain <br />           sections TUNEL staining birc5a ATG-MO (g) birc5b ATG-MO (h) 48 h.p.f. embryos. Knockdown birc5a birc5b induced CNS apoptosis. (i j) Lateral views <br />           elavl3 expression birc5a ATG-MO (i) birc5b ATG-MO (j) 24 h.p.f. embryos. Compared WT, birc5a birc5b MO embryos exhibited lower elavl3 expression, and <br />           similar <span id='am-394' about='xsp:pattern' typeof='owl:Thing'>pattern</span> hif2a MO embryos. (k l) Immunofluorescent staining HuC/HuD transverse brain sections birc5a ATG-MO (k) birc5b ATG-MO (l) <br />           48 h.p.f. embryos. The loss neural differentiation birc5a birc5b MO embryos confirmed deficiency post-mitotic HuC/D expression. (m n) Transverse <br />           brain sections TUNEL staining 48 h.p.f. hif2a ATG-MO embryos injected 50 pg birc5a mRNA (m) birc5b mRNA (n). The intensive apoptosis observed in <br />           hif2a morphants effectively eliminated ectopic addition birc5a birc5b mRNA. (o p), Lateral views elavl3 expression 24 h.p.f. hif2a <br />           ATG-MO embryos injected 50 pg birc5a mRNA (o) birc5b mRNA (p). (q r) Immunofluorescent staining HuC/HuD transverse brain sections 48 h.p.f. <br />           hif2a ATG-MO embryos injected 50 pg birc5a mRNA (q) birc5b mRNA (r). The loss elavl3 expression hif2a morphants rescued vitro transcribed <br />           birc5a birc5b mRNA <br />  <br />  <br />  <br />  <br /> Cell Death Differentiation <br />                                                                                        Integration CNS survival differentiation HIF2a <br />                                                                                       C-Y Ko et al <br />                                                                                                                                                                             1765 <br />  <br />  <br />  <br />  <br /> Figure 7 DNA content analysis flow cytometry. For sample, 30 000 events acquired. In WT 48 h.p.f. embryos (a), 72, 25 3% cells G0/G1 <br /> (2n), S (2nB4n) G2/M (4n) phases, respectively; 5% apoptotic cells (o2n) detected WT cells. hif2a (b) birc5a (c) ATG-MO treatments increased the <br /> percentage cells S G2/M compared WT embryos. The percentage apoptotic cells increased 3&#226;&#8364;&#8220;4-fold compared WT embryos. Treatment with <br /> 50 pg ectopic birc5a mRNA (d) reduced hif2a ATG-MO-induced cell death level comparable wild-type embryos. The percentage cells S G2/M phases <br /> also decreased significantly compared hif2a birc5a morphants <br />  <br />  <br />  <br />  <br /> Figure 8 CNS defects hif2a morphants rescued ectopic injection survivin orthologue mRNA. The percentages normal, moderate severe (characterized <br /> by smaller head size, short curved tail, narrow somites massive CNS apoptosis) morphological phenotypes WT (n &#194;&#188; 50), hif1a ATG-MO (n &#194;&#188; 54), hif2a ATG-MO <br /> (n &#194;&#188; 69), hif2a SPL-MO (n &#194;&#188; 23), hif3a ATG-MO (n &#194;&#188; 25), hif1a, 3a dual ATG-MO (n &#194;&#188; 64), birc5a ATG-MO (n &#194;&#188; 45), birc5b ATG-MO (n &#194;&#188; 35) 48 h.p.f. embryos hif2a <br /> ATG-MO co-injected 50 pg birc5a mRNA (n &#194;&#188; 167) hif2a ATG-MO embryos co-injected 50 pg birc5b mRNA (n &#194;&#188; 262). Ectopic injection birc5a or <br /> birc5b mRNA restored hif2a morphants normal phenotype birc5a mRNA better rescuing capability <br />  <br />  <br />  <br /> zebrafish survivin orthologues (birc5a birc5b) promoters                          involve NPC growth differentiation, have <br /> are enriched multiple HREs, survivin genes                             essential role developmental events. Depletion <br /> are modulated different HIF factors. In human cancer                             HIF1a expression abrogated erythropoiesis and <br /> cells, BIRC5 transcription modulated HIF1a                              reduced hemoglobin content (data shown). It suggests <br /> its direct binding HRE proximate promoter                               sets HIF1a- HIF2a-modulated genes in <br /> region.23 In zebrafish, demonstrate birc5a                           human zebrafish slightly different the <br /> birc5b transcriptions controlled HIF2a,                                discriminative target selectivity HIF1a HIF2a factors <br /> HIF1a. It noteworthy zebrafish HIF1a does                        cross species. <br />  <br />                                                                                                                                                     Cell Death Differentiation <br />                                    Integration CNS survival differentiation HIF2a <br />                                                                                 C-Y Ko et al <br /> 1766 <br />  <br />  <br />  <br />  <br />           Figure 9 Knockdown birc5a birc5b maintains neural progenitor cells proliferating stage blocks maturation. (a&#226;&#8364;&#8220;c) Lateral views nes expression WT <br />           (a), birc5a ATG-MO (b) birc5b ATG-MO (c) 48 h.p.f. embryos. (d&#226;&#8364;&#8220;f) Lateral views pcna expression WT (d), birc5a ATG-MO (e) birc5b ATG-MO (f) 48 h.p.f. <br />           embryos. (g&#226;&#8364;&#8220;i) Immunofluorescent staining PCNA (in red) transverse brain sections WT (g), birc5a ATG-MO (h) birc5b ATG-MO (i) 48 h.p.f. embryos. Nuclei are <br />           labeled DAPI staining (blue). The high levels nes pcna expression following treatment birc5a birc5b MOs indicate NPCs proliferating not <br />           terminally differentiated. (j&#226;&#8364;&#8220;o) Lateral views cdkn1b (j&#226;&#8364;&#8220;l) cdkn1c (m&#226;&#8364;&#8220;o) expression WT (j m), birc5a ATG-MO (k n) birc5b ATG-MO (l o) 48 h.p.f. <br />           embryos. (p&#226;&#8364;&#8220;r) Lateral views ccnd1 expression WT (p), birc5a ATG-MO (q) birc5b ATG-MO (r) 48 h.p.f. embryos. The reduction cdkn1b cdkn1c expression and <br />           increase ccnd1 expression CNS following treatment birc5a birc5b MOs suggest NPCs failed exit cell cycle <br />  <br />  <br />             It shown HIFs important roles                                   differentiation enhances cell survival upregulat- <br />           embryonic cell differentiation proliferation.24 Hypoxic                             ing HIF1a HIF2a.25 However, functions HIFs <br />           preconditioning promotes embryonic stem cell neural                                     cell differentiation elucidated. Here, we <br />  <br /> Cell Death Differentiation <br />                                                                                         Integration CNS survival differentiation HIF2a <br />                                                                                        C-Y Ko et al <br />                                                                                                                                                                           1767 <br />  <br />                                                                                        undergo final differentiation. Ectopic treatment birc5a <br />                                                                                        birc5b mRNA successfully prevented hif2a <br />                                                                                        MO-induced apoptosis morphological abnormality, but <br />                                                                                        restored neural differentiation. It suggests the <br />                                                                                        abrogation differentiation secondary effect elicited by <br />                                                                                        HIF2a depletion loss downstream effectors, <br />                                                                                        Birc5a Birc5b. <br />                                                                                           Previous studies demonstrated close relationship <br />                                                                                        hypoxia-signaling pathway cell-cycle arrest <br />                                                                                        mammalian cells. For instance, overexpression the <br />                                                                                        stable forms HIF1a HIF2a murine cells treatment <br />                                                                                        murine cells hypoxia directly resulted increase in <br />                                                                                        p27 transcription cell-cycle arrest G1 phase.26,27 <br />                                                                                        Moreover, targeted depletion HIF1a chondrocytes <br />                                                                                        resulted decreased p57 expression, enhanced BrdU <br />                                                                                        incorporation cell death.28 We demonstrate loss <br />                                                                                        survivin responsible reductions p27 and <br />                                                                                        p57 expression aberrant neural development is <br />                                                                                        observed hif2a morphant zebrafish embryos. Survivin <br />                                                                                        similar effect cell differentiation mouse <br />                                                                                        erythroid development. Depletion survivin hemato- <br />                                                                                        poietic progenitor cells results aberrant erythroid forma- <br />                                                                                        tion.29 Likewise, earlier studies demonstrated that <br />                                                                                        depletion zebrafish birc5a birc5b transcription evoked <br />                                                                                        profound neuro-developmental, hematopoietic, cardiogenic, <br />                                                                                        vasculogenic angiogenic defects.22 <br />                                                                                           In Drosophila, dying cells trigger compensatory proliferation <br />                                                                                        initiator effector caspase activities.30 In <br />                                                                                        apoptotic proliferating tissues, initiator caspase Dronc <br />                                                                                        coordinates apoptosis compensatory proliferation <br />                                                                                        Jun N-terminal kinase p53 pathways, which <br />                                                                                        turn induce secretion mitogens Decapentaplegic <br /> Figure 10 HIF2a binds birc5a birc5b promoter. (a) HIF2a binds HRE            (Dpp) Wingless (Wg).30,31 In apoptotic differentiating <br /> as confirmed EMSA. COS-1 cells transfected zHif2A-HA                  tissues, effector caspases DrICE Dcp-1 activate the <br /> zARNT1A-HA indicated. Nuclear extracts collected 48 h post-transfection     hedgehog pathway induce compensatory proliferation.32 <br /> followed gel mobility shift assays using HRE oligonucleotides probe.    Hedgehog signaling triggers reentry cells had <br /> The asterisks lanes 3, 4 6 indicate specific HIF2&#226;&#8364;&#8220;HRE complex formed. <br /> NE, nuclear extract; COS-1, nuclear extract COS-1 cells transfection a <br />                                                                                        previously exited cell cycle.32,33 In zebrafish embryos, <br /> control; Hif2A, nuclear extract COS-1 cells transfected pcDNA3-zHif2A-HA;      knockdown hif2a resulted loss expression the <br /> Hif2A &#195;&#190; zARNT1A, nuclear extract COS-1 cells co-transfected pcDNA3-            survivin orthologues, turn caused severe neural <br /> zHif2A-HA pcDNA3-zARNT1A-HA. (b) HIF2a binds birc5a birc5b              progenitor cell death, increased proliferation activity and <br /> promoters brain tissues physiological conditions. A chromatin                 abrogated neural differentiation. This phenomenon cell <br /> immunoprecipitation (ChIP) assay performed polyclonal antibody        death-associated proliferation abrogation differentia- <br /> anti-HIF2a preimmune serum control. Chromatin prepared adult <br />                                                                                        tion zebrafish embryos analogous been <br /> brain tissue immunoprecipitated using polyclonal antibody anti- <br /> HIF2a preimmune serum (IgG) control. The immunoprecipitates                 observed Drosophila apoptosis-induced compensatory <br /> subjected PCR using specific primers spanning HREs birc5a birc5b     proliferation. We hypothesize reentry cell cycle <br /> promoters (shown panel c). The module 5 birc5a modules 2 6 birc5b     causes descendant cells remain progenitor stage <br /> were significantly enriched HIF2a antibody. The rest modules failed       differentiating. These findings suggest a <br /> amplified. A portion chromatin solution (2.4%) used input. The primers       key function HIF2a developing embryos related to <br /> used ChIP assay listed Table 1. (c) Schematic representation         inhibition neural progenitor cell death maintenance of <br /> birc5a (NM_194397), birc5b (NM_145195), human BIRC5 (NM_001012271) and <br /> mouse Birc5 (NM_001012273) promoters. The putative binding sites HIF2,             neural differentiation functions downstream <br /> including HRE1 (ACGTG, black bars) HRE2 (GCGTG, gray bars), indicated.         survivin orthologues (Figure 11). Depletion HIF2a the <br /> The position DNA modules analyzed ChIP-PCR assays indicated        survivin orthologues causes massive neural progenitor cell <br /> boxes. The amplified fragments ChIP assays (panel b), including module          death, induces compensatory proliferation abro- <br /> 5 birc5a promoter modules 2 6 birc5b promoter, indicated      gates neural differentiation. <br /> black boxes                                                                               It demonstrated inhibition human HIF2a <br />                                                                                        promotes tumor cell death p53 activation. HIF2a <br />                                                                                        depletion promotes p53-mediated responses clear cell <br /> demonstrate HIF2a depletion causes massive NPC                              renal cell carcinoma (ccRCC) disrupting cellular redox <br /> apoptosis stimulates remaining NPCs prolifera-                            homeostasis, permits ROS accumulation and <br /> tion. Nevertheless, newly produced NPCs did                                  DNA damage.14 Although similar level p53 accumulation <br />  <br />                                                                                                                                                   Cell Death Differentiation <br />                                     Integration CNS survival differentiation HIF2a <br />                                                                                  C-Y Ko et al <br /> 1768 <br />  <br />                                                                                                   (9 ng). To confirm specificity hif2a ATG-MO, second morpholino that <br />                                                                                                   blocks pre-mRNA splicing hif2a exon 2&#226;&#8364;&#8220;intron 2 junction also <br />                                                                                                   designed: hif2a SPL-MO, 50 -GACTGTGTACCTGAGTTGACGAGTT-30 (6 ng). <br />                                                                                                   Aliquots morpholinos (4.6 nl each) injected 1&#226;&#8364;&#8220;2 cell-stage <br />                                                                                                   embryos using Drummond Nanoject (Drummond, Broomall, PA, USA). For capped <br />                                                                                                   RNA synthesis, full-<span id='am-2' about='xsp:length' typeof='owl:Thing'>length</span> cDNAs hif2a, birc5a birc5b cloned the <br />                                                                                                   pT7TS vector. After linearization, plasmids transcribed vitro T7 RNA <br />                                                                                                   polymerase mMESSAGE mMACHINE kit Ambion (Austin, TX, USA). <br />                                                                                                   For rescue assay, 75 pg purified hif2a mRNA 50 pg purified birc5a and <br />                                                                                                   birc5b mRNAs co-injected hif2a ATG-MO 1&#226;&#8364;&#8220;2 cell-stage embryos. <br />  <br />                                                                                                   In situ hybridization. The hif2a (DQ375242, bases 2557&#226;&#8364;&#8220;3137), birc5a <br />                                                                                                   (NM_194397, bases 38&#226;&#8364;&#8220;485), birc5b (NM_145195, bases 2&#226;&#8364;&#8220;421), elavl3/HuC <br />                                                                                                   (BC065343, bases 55&#226;&#8364;&#8220;554), nes (XM_001919887, bases 54&#226;&#8364;&#8220;754), pcna <br />                                                                                                   (BC064299, bases 255&#226;&#8364;&#8220;1367), p27/cdkn1b (NM_212792, bases 611&#226;&#8364;&#8220;1262), <br />                                                                                                   p57/cdkn1c (NM_001002040, bases 50&#226;&#8364;&#8220;1133) ccnd1 (NM_131025, bases <br />                                                                                                   1094&#226;&#8364;&#8220;2213) templates amplified cDNA cloned pGEM-T-easy <br />                                                                                                   vector (Promega, Madison, WI, USA). To generate probes, linearized plasmids <br />                                                                                                   used templates vitro transcription DIG RNA labeling kit <br />                                                                                                   (Roche Applied Science, Indianapolis, IN, USA) according manufacturer&#226;&#8364;&#8482;s <br />                                                                                                   instructions. Whole-mount situ hybridization performed essentially as <br />                                                                                                   described previously.35 Nitro blue tetrazolium/bromo-4-chloro-3-indolyl phosphate <br />                                                                                                   (Roche Applied Science) served substrate color development. Double <br />                                                                                                   fluorescent situ hybridization38 performed using DIG-UTP FITC-UTP- <br />                                                                                                   labeled RNA probes followed sequential detection using HRP-labeled anti-DIG <br />                                                                                                   HRP-labeled anti-FITC antibodies (Roche, Indianapolis, IN, USA) and <br />                                                                                                   fluorescent tyramide amplification. Following RNA probe hybridization, embryos <br />           Figure 11 A proposed mechanism HIF2a deprivation induces NPC                   blocked 10% serum, 1% BSA incubated HRP anti-FITC <br />           apoptosis blocks neural differentiation. Knockdown hif2a results            1 : 500 dilution overnight 10% serum, 1% BSA. After washing, anti-FITC <br />           reduction survivin orthologues, turn causes apoptosis induces       antibody visualized TSA Plus Fluorescein Solution (Perkin-Elmer, <br />           complementary proliferation neighboring cells. The replenished proliferating cells   Waltham, MA, USA) 45 min, dehydrated methanol quenched 1% <br />           remain cell cycle terminally differentiate                            H2O2 methanol 30 min. After rehydrating, embryos blocked and <br />                                                                                                   incubated HRP anti-DIG 1 : 500 dilution 4 h, washed reacted <br />                                                                                                   TSA Plus Cy3 solution (Perkin-Elmer) 45 min. Embryos cleared in <br />           observed hif2a morphant embryos (data not <br />                                                                                                   glycerol, mounted viewed Zeiss LSM 510 confocal fluorescence <br />           shown), demonstrated inhibition p53 expression did                           microscope (Zeiss, Jena, Germany). <br />           prevent massive apoptosis hif2a morphant embryos. <br />           Similarly, HIF2a inhibition-induced massive apoptosis                               Flow cytometric DNA content analysis. After removal chorion and <br />           observed p53 mutant line. Instead, demon-                                yolk, 20 embryos washed PBS transferred collection tube. Embryos <br />           strated massive apoptosis observed hif2a morphant                           digested trypsin (0.05%)/EDTA (1 mM) solution 10 min room <br />           embryos caused depletion survivin orthologues.                             temperature completely dissociated single-cell suspensions by <br />                                                                                                   pipetting. Trypsin inactivated incubation CaCl2 (1 mM)/lamb serum <br />           Ectopic treatment survivin mRNAs rescued defects <br />                                                                                                   (5%), suspension passed 40-mm filter (BD Falcon, <br />           induced HIF2a inhibition, indicating survivins act                              Franklin Lakes, NJ, USA). The cells centrifuged 2000 r.p.m. 41C, washed <br />           downstream HIF2a maintain cell survival. It noteworthy                         PBS fixed 70% ethanol overnight  201C. After fixation, cells were <br />           expression survivin/BIRC5 ccRCC inversely                                centrifuged resuspended PBS. The suspended cells stained by <br />           correlated cancer-specific survival.34 It interesting                      treatment RNase A (200 mg/ml) propidium iodide (50 ng/ml) (Sigma, <br />           examine correlation HIF2a survivin                                   St. Louis, MO, USA) 15 min 41C dark. In all, 30 000 events were <br />           expression ccRCC patients. Our results shed light                               acquired sample propidium iodide-positive cells quantified flow <br />                                                                                                   cytometry (BD FACSCanto, Franklin Lakes, NJ, USA). Cells DNA content less <br />           cancer cells protect HIF                              2 N (G0/G1) cells classified apoptotic cells cells distribute <br />           survivin pathways.                                                                      2 4 N (G2/M) cells S-phase cells. <br />  <br />                                                                                                   RT-qPCR. Total RNA extracted embryos using TRIzol (Invitrogen, <br />           Materials Methods                                                                   Carlsbad, CA, USA) followed DNase I treatment (Roche) used cDNA <br />           Morpholino mRNA injection. Adult zebrafish maintained                      synthesis Superscript-II (Invitrogen). Quantitative (q)PCR performed using <br />           staged described previously.35 The tp53M214K fish line generated              Power SIBER Q-PCR Master Mix (BioNoVas, Toronto, Canada) Bio-Rad, <br />           laboratory Thomas Look36 obtained Taiwan Zebrafish Core Facility        iQ5 Gradient Real Time PCR System (Bio-Rad, Hercules, CA, USA). qPCR <br />           Taiwan. All embryos grown 0.003% 1-phenyl-2-thiourea 14 h.p.f.      conditions 951C 3 min 40 cycles 951C 15 s 601C for <br />           28.51C block pigmentation mediate visualization. Morpholinos (Gene Tools,        1 min. The following primers designed using Primer Express Software <br />           Philomath, OR, USA) designed Danio rerio hif1a, hif2a hif3a            version 3.0 (Applied Biosystems, Carlsbad, CA, USA): <br />           (GenBank accession AY326951, DQ375242 AY330295, respectively). The <br />           birc5a, birc5b p53 ATG-MOs designed described previously.30,37 The             birc5a forward, 50 -GTGGCCACGCGATTGAA-30 ; <br />           translation-blocking morpholino (ATG-MO) sequences dosages applied                birc5a reverse, 50 -CAGTCTGGATGATCTGGTTTCTCTT-30 ; <br />           follows: hif1a ATG-MO, 50 -CAGTGACAACTCCAGTATCCATTCC (6 ng); hif2a                      birc5b forward, 50 -GGAGCGACTTCGCATCTACAT-30 ; <br />           ATG-MO, 50 -CGCTGTTCTCGCGTAATTCCCGCAG-30 (6 ng); hif3a ATG-MO,                             birc5b reverse, 50 -ACCTCATCACGAAAGTAGGCAATC-30 ; <br />           CCTTTTCGACGTAGAGTTCACCATC (12 ng); birc5a ATG-MO, 50 -TGCAAGATC                            cdkn1b forward, 50 -TGGGTCGTGCCACCAATTA-30 ; <br />           CATTTTGTGGGAGGTT-30 (4 ng); birc5b ATG-MO, 50 -GAAGTCTTTTTTCATAA                           cdkn1b reverse, 50 -TGCATCACGTTTCACCACAGA-30 ; <br />           CTATACAT-30 (12 ng); p53 ATG-MO 50 -GCGCCATTGCTTTGCAAGAATTG-30                             cdkn1c forward, 50 -AACAGCACGCCGCAAATT-30 ; <br />  <br /> Cell Death Differentiation <br />                                                                                         Integration CNS survival differentiation HIF2a <br />                                                                                        C-Y Ko et al <br />                                                                                                                                                                                   1769 <br />  <br /> Table 1 Primer sequences used ChIP assay <br />  <br /> Module                     Forward                                                       Reverse                                                           Positions <br />  <br /> 5a-1                       CTACATGCTGTGGTCGAACT                                          CCAACCGACGAATGTTTGAA                                          +70B 169 bp <br /> 5a-2                       ACGTGCTGGATAAGTTGACG                                          ATCATTGCCACTTGACCATG                                          2258B 2453 bp <br /> 5a-3                       TGGTTACCAGGTTCTAGCTC                                          CTCCAGAATTAAGAGACAGG                                          3397B 3568 bp <br /> 5a-4                       GTATGTGTCCAGCAGTGGTT                                          TCTCTCCGTCTCCTTTCAGA                                          4085B 4239 bp <br /> 5a-5                       AGACTCATCAGACCAGGCAA                                          GCAGAAGAGCTTCTCTGAAT                                          5447B 5628 bp <br /> 5a-6                       CTAACCACTGAGCCACCTAA                                          GCATCATAGATGTGCAGCAG                                          6051B 6303 bp <br /> 5a-7                       GGCTATGTTTGCCACCACAA                                          AGGACTCATTACAGCGCATTC                                         7104B 7267 bp <br /> 5a-8                       ATCCAGTCAACAGCCACAGA                                          GAAGGGTTAACAATGCTGAC                                          9678B 9803 bp <br />  <br /> 5b-1                       GAGACATCGTCCTTCAAAC                                           CTTCGCTGTAAGATGACACA                                           189B 357 bp <br /> 5b-2                       CCATTCCTTTATGACCACAG                                          CTGCACGTACATGATGTGAA                                          1262B 1475 bp <br /> 5b-3                       CAGCTTGTTAAGGATCAGGC                                          GTTGCTTCCATGTGATTGGC                                          1961B 2123 bp <br /> 5b-4                       CTGGTTCATTCCGCTGTGAT                                          GACTGAATTGTGTGGAACCC                                          4357B 4561 bp <br /> 5b-5                       CACTGTACCAGTTTGTCTGG                                          CTAAACCCAACGGACAGTGT                                          5162B 5363 bp <br /> 5b-6                       GGTGTAAGTAGTGTGTTCAC                                          GCAAAGCTGAGGTAGTTGAG                                          7197B 7333 bp <br /> 5b-7                       ACTTCCATGTGTGAACCAGC                                          CTTCAACTGTACGTGTTCAC                                          7960B 8072 bp <br /> 5b-8                       GCAGAGAAGCATACTAATATGTTGA                                     AGGAGATTCCTCCCATTGTG                                          8489B 8682 bp <br />  <br />  <br />    cdkn1c reverse, 50 -TCGACTCCACGACCCTCTTT-30 ;                                       nuclear extracts normal transfected COS-1 cells mixed biotin- <br />    ccnd1 forward, 50 -TGTGATGAATCTCTTCGTCTTTGTT-30 ;                                   labeled probes premixed binding reagents (Thermo, Waltham, MA, USA) and <br />    ccnd1 reverse, 50 -GTCCCATGACGCCTTTGG-30 ;                                          incubated room temperature 30 min. For competitive experiments, 50   <br />    b-actin forward, 50 -CCCCGAGAGGACAACAATGTA-30 ;                                     normal mutant probes added. Unbound DNA probes resolved from <br />    b-actin reverse, 50 -TGAGGAGGGCAAAGTGGTAAA-30 .                                     protein&#226;&#8364;&#8220;DNA complexes electrophoresis 10% polyacrylamide gel. After <br />                                                                                        electrophoresis, DNA oligonucleotides transferred nylon membrane <br /> Duplicate mean values calculated according Ct quantification               (Pall, Washington, NY, USA) UV crosslinked. Biotin-labeled DNAs were <br /> method using b-actin transcript levels reference normalization.             detected using Lightshift Chemiluminescent EMSA Kit according the <br /> Relative quantification determined using A&#194;&#168;A&#194;&#168;Ct method: relative               manufacturer&#226;&#8364;&#8482;s instructions (Thermo). <br /> expression &#194;&#188; 2 DDCt. <br />                                                                                        Immunostaining. Zebrafish acetylated tubulin IHC performed as <br /> Apoptosis detection. Zebrafish embryos 24 h.p.f. dechorionated             described The Zebrafish Book.35 Briefly, embryos fixed 4% <br /> incubated 30 min 5 mg/ml acridine orange E3 medium (5 mM NaCl, 0.17 mM       paraformaldehyde (PFA) 41C, dehydrated stored MeOH. After <br /> KCl, 0.33 mM CaCl2 0.33 mM MgSO4). The embryos subsequently                   rehydration, embryos treated proteinase K, fixed 4% PFA, washed <br /> washed repeatedly E3 medium. For microscopic examination, embryos              0.3% Triton X-100 PBS (PBT) subsequently blocked 1 h PBT <br /> transferred 0.01% ethyl 3-aminobenzoate methanesulfonate (tricaine, Sigma).       containing 5% horse serum. Embryos incubated mouse anti-acetylated <br /> TUNEL assays performed using situ cell death detection kit (POD,            tubulin antibody (1 : 1000, Sigma T-6793).30 After washes PBT, <br /> Roche) described manufacturer. For combined fluorescent nes DIG situ/     embryos blocked 1 h incubated goat anti-rabbit Alexa Fluor 568 <br /> TUNEL staining, embryos situ hybridized fluorescence nes RNA        secondary antibody (Sigma). Images acquired using Zeiss Axioskop 2 <br /> probe followed TUNEL assay.39 The protocol fluorescence situ hybridization    fluorescence microscope (Zeiss). For cross-sectional analysis,35 embryos were <br /> is described above. The RNA probe labeled DIG. After conjugated         embedded OCT mount medium (Sakura Finetek, Torrance, CA, USA), Cryostat <br /> HRP anti-DIG antibody (Perkin-Elmer), signal detected TSA Plus              sectioned (CM-1900, Leica, Nussloch, Germany) mounted glass slides <br /> Fluorescein Solution (Perkin-Elmer). This followed TUNEL assay. The             (Superfrost Plus, J1800AMNZ). The primary antibodies included mouse anti-HuC/ <br /> embryos manually de-yolked images captured Zeiss LSM            HuD (Molecular Probes, Eugene, OR, USA, 1 : 1000) monoclonal anti-PCNA <br /> 510 confocal microscope.                                                               (Sigma, P8825, 1 : 1000). After washes PBT, slides incubated with <br />                                                                                        goat anti-rabbit Alexa Fluor 568 secondary antibody (Sigma). After repeated washes, <br /> Chromatin immunoprecipitation. ChIP performed using Magna                       sections counterstained 4,6-diamidino-2-phenylindole (DAPI, Sigma) 10 ng/ <br /> ChIP Protein A magnetic beads (Millipore, Billerica, MA, USA) according         ml visualize nuclei. Fluorescence UV light images acquired using a <br /> manufacturer&#226;&#8364;&#8482;s instructions. Briefly, adult brain tissues crosslinked        fluorescence microscope (OLYMPUS BX 51, Olympus, Tokyo, Japan). <br /> formaldehyde chromatin isolated. The isolated chromatin sonicated to <br /> an average size 200&#226;&#8364;&#8220;300 bp. Protein A magnetic beads incubated <br /> with antibody HIF2a (ChIP grade rabbit polyclonal antibody purchased           Conflict interest <br /> from GeneTex (Irvine, CA, USA), GTX103707) control IgG 41C 1 h. <br /> Immunoprecipitation reactions performed incubating magnetic beads-             The authors declare conflict interest. <br /> linked antibody chromatin overnight 41C. The immunoprecipitated <br /> chromatin complexes washed TE buffer protein&#226;&#8364;&#8220;DNA crosslinks <br /> were reverse crosslinked proteinase K digestion 621C 2 h followed 951C    Acknowledgements. We thank SY Chen CT Shih (NTOU) critical <br /> for 10 min. The DNA purified spin columns eluted elution          discussions manuscript, J Chang (NTOU) statistical analysis, <br /> buffer. Immunoprecipitated DNA input DNA used templates PCR            KY Huang, WH Liao (Academia Sinica) confocal microscope photograph, MS Yu <br /> amplification (30 cycles). The PCR primers used ChIP assay listed Table 1.   (Taiwan Zebrafish Core Facility, NSC 99-2321-B-400-0001) providing the <br />                                                                                        tp53M214K fish YC Cheng (CGU) reagents fish lines. This study was <br /> Electrophoretic mobility shift assay. After COS-1 cells transfected               supported grants National Science Council (Taiwan), Ministry of <br /> with indicated plasmids 48 h, nuclear extracts prepared                Education Center Excellence Marine Bioenvironmental and <br /> minipreparation method described previously.40 The nuclear extracts            Biotechnology (NTOU) CHH. <br /> preserved  701C use. Oligonucleotide probe containing HRE core <br /> sequence (50 -CATCGTCCTTCAAACGTGTAACTAAGTTCA-30 ) mutant probe <br /> (50 -CATCGTCCTTCAAGTACATAACTAAGTTCA-30 ) synthesized labeled                    1. Lopez-Barneo J, Pardal R, Ortega-Saenz P. Cellular mechanisms oxygen sensing. <br /> with 50 -end biotin (Purigo, Taipei, Taiwan). For EMSA reaction, 20 mg             Annu Rev Physiol 2001; 63: 259&#226;&#8364;&#8220;287. <br />  <br />  <br />                                                                                                                                                           Cell Death Differentiation <br />                                        Integration CNS survival differentiation HIF2a <br />                                                                                     C-Y Ko et al <br /> 1770 <br />  <br />            2. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. The                 22. Delvaeye M, De Vriese A, Zwerts F, Betz I, Moons M, Autiero M et al. Role the <br />               tumour suppressor protein VHL targets hypoxia-inducible factors oxygen-dependent               2 zebrafish survivin genes vasculo-angiogenesis, neurogenesis, cardiogenesis and <br />               proteolysis. Nature 1999; 399: 271&#226;&#8364;&#8220;275.                                                            hematopoiesis. BMC Dev Biol 2009; 9 ARTN 25. <br />            3. Hara S, Hamada J, Kobayashi C, Kondo Y, Imura N. Expression characterization            23. Peng XH, Karna P, Cao ZH, Jiang BH, Zhou MX, Yang L. Cross-talk epidermal <br />               hypoxia-inducible factor (HIF)-3 alpha human kidney: suppression HIF-mediated gene           growth factor receptor hypoxia-inducible factor-1 alpha signal pathways increases <br />               expression HIF-3 alpha. Biochem Biophys Res Commun 2001; 287: 808&#226;&#8364;&#8220;813.                          resistance apoptosis up-regulating survivin gene expression. J Biol Chem 2006; 281: <br />            4. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH et al. Cellular                    25903&#226;&#8364;&#8220;25914. <br />               developmental control O-2 homeostasis hypoxia-inducible factor 1 alpha. Genes Dev        24. Mazumdar J, Dondeti V, Simon MC. Hypoxia-inducible factors stem cells cancer. <br />               1998; 12: 149&#226;&#8364;&#8220;162.                                                                                 J Cell Mol Med 2009; 13: 4319&#226;&#8364;&#8220;4328. <br />            5. Ryan HE, Lo J, Johnson RS. HIF-1 alpha required solid tumor formation               25. Francis KR, Wei L. Human embryonic stem cell neural differentiation enhanced cell <br />               embryonic vascularization. EMBO J 1998; 17: 3005&#226;&#8364;&#8220;3015.                                             survival promoted hypoxic preconditioning. Cell Death Dis 2010; 1: e22. <br />            6. Yoon D, Pastore YD, Divoky V, Liu EL, Mlodnicka AE, Rainey K et al. Hypoxia-inducible          26. Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS. Hypoxia-inducible <br />               factor-1 deficiency results dysregulated erythropoiesis signaling iron homeostasis       factor 1 alpha essential cell cycle arrest hypoxia. Mol Cell Biol 2003; 23: <br />               mouse development. J Biol Chem 2006; 281: 25703&#226;&#8364;&#8220;25711.                                             359&#226;&#8364;&#8220;369. <br />            7. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H et al. Loss                   27. Hackenbeck T, Knaup KX, Schietke R, Schodel J, Willam C, Wu XQ et al. HIF-1 HIF-2 <br />               HIF-2 inhibition VEGF impair fetal lung maturation, treatment                       induction sufficient achieve cell cycle arrest NIH3T3 mouse fibroblasts independent <br />               VEGF prevents fatal respiratory distress premature mice. Nat Med 2002; 8:                  hypoxia. Cell Cycle 2009; 8: 1386&#226;&#8364;&#8220;1395. <br />               702&#226;&#8364;&#8220;710.                                                                                       28. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS. Hypoxia in <br />            8. Peng J, Zhang LY, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-                    cartilage: HIF-1 alpha essential chondrocyte growth arrest survival. Genes Dev <br />               inducible factor 2 alpha plays important role vascular remodeling. Proc Natl Acad Sci        2001; 15: 2865&#226;&#8364;&#8220;2876. <br />               USA 2000; 97: 8386&#226;&#8364;&#8220;8391.                                                                       29. Gurbuxani S, Xu YF, Keerthivasan G, Wickrema A, Crispino JD. Differential <br />            9. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ et al. Multiple organ                   requirements survivin hematopoietic cell development. Proc Natl Acad Sci USA <br />               pathology, metabolic abnormalities impaired homeostasis reactive oxygen species             2005; 102: 11480&#226;&#8364;&#8220;11485. <br />               Epas1( / ) mice. Nat Genet 2003; 35: 331&#226;&#8364;&#8220;340.                                               30. Ryoo HD, Gorenc T, Steller H. Apoptotic cells induce compensatory cell proliferation <br />           10. Tomita S, Ueno M, Sakamoto M, Kitahama Y, Ueki M, Maekawa N et al. Defective brain                 JNK wingless signaling pathways. Dev Cell 2004; 7: 491&#226;&#8364;&#8220;501. <br />               development mice lacking Hif-1 alpha gene neural cells. Mol Cell Biol 2003; 23:      31. Wells BS, Yoshida E, Johnston LA. Compensatory proliferation Drosophila imaginal <br />               6739&#226;&#8364;&#8220;6749.                                                                                         discs requires Dronc-dependent p53 activity. Curr Biol 2006; 16: 1606&#226;&#8364;&#8220;1615. <br />           11. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization           32. Fan Y, Bergmann A. Distinct mechanisms apoptosis-induced compensatory proliferation in <br />               wild-type p53 hypoxia-inducible factor 1 alpha. Nature 1998; 392: 405&#226;&#8364;&#8220;408.                      proliferating differentiating tissues Drosophila eye. Dev Cell 2008; 14: 399&#226;&#8364;&#8220;410. <br />           12. Bruick RK. Expression gene encoding proapoptotic Nip3 protein induced         33. Fan Y, Bergmann A. Apoptosis-induced compensatory proliferation. The cell dead. Long <br />               hypoxia. Proc Natl Acad Sci USA 2000; 97: 9082&#226;&#8364;&#8220;9087.                                               live cell!. Trends Cell Biol 2008; 18: 467&#226;&#8364;&#8220;473. <br />           13. Dong Z, Venkatachalam MA, Wang JZ, Patel Y, Saikumar P, Semenza GL et al.                      34. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML et al. Clear cell renal <br />               Up-regulation apoptosis inhibitory protein IAP-2 hypoxia &#226;&#8364;&#8220; HIF-1-independent                 cell carcinoma: gene expression analyses identify potential signature tumor <br />               mechanisms. J Biol Chem 2001; 276: 18702&#226;&#8364;&#8220;18709.                                                    aggressiveness. Clin Cancer Res 2005; 11: 5128&#226;&#8364;&#8220;5139. <br />           14. Bertout JA, Majmundar AJ, Gordan JD, Lam JC, Ditsworth D, Keith B et al. HIF2 alpha            35. Westerfield M (ed.). The Zebrafish Book. A Guide Laboratory Use Zebrafish <br />               inhibition promotes p53 pathway activity, tumor cell death, radiation responses. Proc          (Danio rerio). 4th edn. University Oregon Press: Eugene, 2000. <br />               Natl Acad Sci USA 2009; 106: 14391&#226;&#8364;&#8220;14396.                                                      36. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CDM et al. tp53 <br />           15. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed              mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci <br />               cancer lymphoma. Nat Med 1997; 3: 917&#226;&#8364;&#8220;921.                                                     USA 2005; 102: 407&#226;&#8364;&#8220;412. <br />           16. Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL et al. Survivin             37. Ma ACH, Lin R, Chan PK, Leung JCK, Chan LYY, Meng A et al. The role survivin in <br />               inner centromere protein INCENP similar cell-cycle localization gene <span id='am-238' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-239' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-240' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-243' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-245' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-261' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-268' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-269' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-272' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-275' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-277' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-279' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-286' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-291' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-294' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span>knockout</span>             angiogenesis zebrafish embryonic development. BMC Dev Biol 2007; 7 ARTN 50. <br />               phenotype. Curr Biol 2000; 10: 1319&#226;&#8364;&#8220;1328.                                                      38. Brend T, Holley SA. Zebrafish mount high-resolution double fluorescent situ <br />           17. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated         hybridization. J Vis Exp 2009: (25); http://www.jove.com/index/Details.stp?ID=1229, <br />               expression novel cancer anti-apoptosis gene survivin human mouse                     doi:10.3791/1229. <br />               differentiation. Am J Pathol 1998; 152: 43&#226;&#8364;&#8220;49.                                                 39. Chen HL, Yuh CH, Wu KK. Nestin essential zebrafish brain eye development <br />           18. Jiang YY, Bruin A, Caldas H, Fangusaro J, Hayes J, Conway EM et al. Essential role          control progenitor cell apoptosis. PLoS One 2010; 5: e9318. <br />               survivin early brain development. J Neurosci 2005; 25: 6962&#226;&#8364;&#8220;6970.                           40. Deryckere F, Gannon F. A one-hour minipreparation technique extraction of <br />           19. Altieri DC. Validating survivin cancer therapeutic target. Nat Rev Cancer 2003;               DNA-binding proteins animal tissues. Biotechniques 1994; 16: 405. <br />               3: 46&#226;&#8364;&#8220;54. <br />           20. Hsieh CS, Ko CY, Chen SY, Liu TM, Wu JS, Hu CH et al. In vivo long-term continuous <br />               observation gene expression zebrafish embryo nerve systems using harmonic                           This work licensed Creative Commons <br />               generation microscopy morphant technology. J Biomed Opt 2008; 13: 064041.                                Attribution-NonCommercial-No Derivative Works 3.0 Unported <br />           21. Rojas DA, Perez-Munizaga DA, Centanin L, Antonelli M, Wappner P, Allende ML et al. <br />               Cloning hif-1 alpha hif-2 alpha mRNA expression pattern development       License. To view copy license, visit http://creativecommons. <br />               zebrafish. Gene Expr Patterns 2007; 7: 339&#226;&#8364;&#8220;345.                                                org/licenses/by-nc-nd/3.0 <br />  <br />  <br />  <br />  <br /> Cell <br /> </body></html>